WEBULL

EssilorLuxottica Société Anonyme (ENXTPA:EL) Results Put Its Valuation Narrative Back In Focus

Simply Wall St · 1d ago

EssilorLuxottica Société anonyme (ENXTPA:EL) is in focus after its first half 2026 earnings, with higher sales, net income and earnings per share, alongside a small immediate share price decline.

See our latest analysis for EssilorLuxottica Société anonyme.

The first half 2026 results are set against a weaker share price backdrop for EssilorLuxottica Société anonyme, with the stock down 36.48% on a year-to-date share price return and a 34.41% decline in the 1-year total shareholder return. The latest 1-day gain of 1.96% hints at slightly improving short-term momentum around the €168.65 level.

If EssilorLuxottica Société anonyme's recent moves have you reassessing your watchlist, this can be a good moment to widen your scope and check out 107 top founder-led companies

EssilorLuxottica Société anonyme now trades about 41% below one estimate of intrinsic value and around 46% below the average analyst price target. Is the market being too cautious after the revenue miss, or sensibly discounting the risks?

Most Popular Narrative: 35.5% Undervalued

The most followed narrative sees EssilorLuxottica Société anonyme’s fair value at about €261.48, well above the recent €168.65 close, which is a sizeable gap that hinges on a specific growth story and margin profile.

Investments in smart eyewear, AI-enabled vision solutions, and MedTech (Ray-Ban Meta, Oakley Meta, Nuance Audio, acquisition of Optegra Eye Clinics) capitalize on long-term demand for technologically advanced and personalized eye health platforms. This is expected to catalyze product mix upgrades and higher ASPs, which in turn is anticipated to benefit gross margin and future earnings.

Read the complete narrative.

Want to see what is baked into that valuation gap? The narrative focuses on steady revenue expansion, improving margins and a richer product mix built around higher value eyewear. The key question is how those moving parts translate into future earnings power and the fair value number attached to EssilorLuxottica Société anonyme.

Result: Fair Value of €261.48 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story around EssilorLuxottica Société anonyme can shift if smart eyewear adoption proves slower than analysts expect or if tariff and inflation pressures keep squeezing margins.

Find out about the key risks to this EssilorLuxottica Société anonyme narrative.

Another View On EssilorLuxottica Société anonyme’s Valuation

The narrative and fair value estimate around €261.48 rely heavily on future earnings. A simpler cross check looks at today’s P/E of 33.5x, which sits above the European Medical Equipment industry on 26.5x and the fair ratio of 26.6x. That points to a richer pricing that could compress if expectations cool.

For context on what that gap might mean for both downside risk and potential opportunity if sentiment shifts, it helps to see how this valuation compares across peers and time, then decide which set of assumptions you find more realistic. See what the numbers say about this price — find out in our valuation breakdown.

ENXTPA:EL P/E Ratio as at Jul 2026
ENXTPA:EL P/E Ratio as at Jul 2026

Next Steps

If the mix of caution and optimism around EssilorLuxottica Société anonyme feels conflicting, do not wait too long to review the data yourself and weigh the trade offs using the 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond EssilorLuxottica Société anonyme?

If EssilorLuxottica Société anonyme is already on your radar, do not stop there. The next step is broadening your opportunity set with focused stock ideas.

  • Target potential value opportunities by checking companies that screen as 250 high quality undervalued stocks based on strong fundamentals and pricing that may not fully reflect their financial profile.
  • Strengthen your income game by reviewing businesses filtered as 440 dividend fortresses for investors who care about sizeable yields backed by solid underlying metrics.
  • Prioritise resilience by assessing companies highlighted in the 304 resilient stocks with low risk scores that emphasise balance sheet strength and lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.